Atopic Dermatitis

FDA Accepts Phase 1 Clinical Trials of Exosome Therapy for AD
November 08, 2022

Brexogen Inc.’s exosome therapy is the first entry of a clinical trial of exosome treatment for atopic dermatitis.

Oral Agents for the Treatment of Atopic Dermatitis
November 08, 2022

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, talk about the use of oral systemic agents and what they’ve learned about the patient experience from the use of these agents.

The Benefits of Topical Ruxolitinib
November 08, 2022

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, examine the clinical context for the approval of topical ruxolitinib and its role in the treatment armamentarium.

Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic Dermatitis
November 03, 2022

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.

The JAK-STAT Pathway and the Mechanisms of JAK Inhibitors
November 01, 2022

Thought leaders discuss why JAK inhibitors are well suited for the management of itch and inflammation in the treatment of moderate to severe atopic dermatitis.

A Changing Treatment Landscape in Atopic Dermatitis
November 01, 2022

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the recent trajectory of the atopic dermatitis therapeutic spectrum, notably how several newer approvals have changed how clinicians approach treatment.

A Young Physician's Guide to Diagnosing Atopic Dermatitis
October 23, 2022

At the 2022 Fall Clinical Dermatology Conference, one clinician discusses history, definitions, and diagnosis for this common skin affliction.

JAK Inhibitors for the Management of Atopic Dermatitis
October 21, 2022

Lisa Swanson, MD, FAAD, and James Q. Del Rosso, DO, FAOCD, FAAD, gave an in-depth discussion on Janus kinase (JAK) inhibitors for the management of atopic dermatitis at the 2022 Fall Clinical Dermatology Conference.

Phase 2a Clinical Trial Enrollment for AD Passes Halfway Point
October 18, 2022

Alphyn Biologics’ study of AB-101a also evaluates patients who suffer from bacterial infections associated with atopic dermatitis.

The Cutaneous Connection: Atopic Dermatitis for Adolescents During Changing Weather
October 17, 2022

In this episode, Jeffrey M. Cohen, MD, a board-certified medical dermatologist and the director of the Psoriasis Treatment Program at the Yale School of Medicine, discusses treatment options for adolescents with atopic dermatitis, how the changing seasons can affect flare-ups, and what caregivers can do at home to help prevent extreme itching.